Corso A - Search Results

1

Transient response of myeloma clone to pamidronate therapy.

Corso A, Astori C, Orlandi E, Zappasodi P, Arcaini L, Bernasconi C. Corso A, et al. Haematologica. 1999 Aug;84(8):759-60. Haematologica. 1999. PMID: 10457421 No abstract available.

2

Plateau phase in multiple myeloma: an end-point of conventional-dose chemotherapy.

Corso A, Nozza A, Lazzarino M, Klersy C, Zappasodi P, Arcaini L, Bernasconi C. Corso A, et al. Haematologica. 1999 Apr;84(4):336-41. Haematologica. 1999. PMID: 10190948

3

Advantages of using thalidomide for the management of refractory myeloma patients.

Corso A, Lorenzi A, Orlandi E, Astori C, Mangiacavalli S, Lazzarino M. Corso A, et al. Haematologica. 2002 Mar;87(3):327-8. Haematologica. 2002. PMID: 11869949

4

A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma.

Corso A, Arcaini L, Caberlon S, Zappasodi P, Mangiacavalli S, Lorenzi A, Rusconi C, Troletti D, Maiocchi MA, Pascutto C, Morra E, Lazzarino M. Corso A, et al. Haematologica. 2002 Oct;87(10):1041-5. Haematologica. 2002. PMID: 12368158

5

Early changes in bone marrow morphology induced by thalidomide in refractory myeloma patients.

Corso A, Lorenzi A, Zappasodi P, Invernizzi R, Vanelli L, Lazzarino M. Corso A, et al. Haematologica. 2003 Aug;88(8):958-60. Haematologica. 2003. PMID: 12935985 Review. No abstract available.

6

Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients.

Corso A, Arcaini L, Mangiacavalli S, Astori C, Orlandi E, Lorenzi A, Passamonti F, Klersy C, Pascutto C, Canevari-Sciorati A, Lazzarino M. Corso A, et al. Haematologica. 2001 Apr;86(4):394-8. Haematologica. 2001. PMID: 11325645

7

The irreplaceable image. Thalidomide in refractory myeloma patients: early changes in bone marrow cellularity.

Zappasodi P, Lorenzi A, Corso A. Zappasodi P, et al. Among authors: corso a. Haematologica. 2001 Apr;86(4):448. Haematologica. 2001. PMID: 11325662 No abstract available.

8

Urinary proteins in multiple myeloma: strong correlation with the indices of tumor burden.

Zappasodi P, Pascutto C, Bosoni T, Corso A. Zappasodi P, et al. Among authors: corso a. Haematologica. 2001 Aug;86(8):878. Haematologica. 2001. PMID: 11524253 No abstract available.

9

The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.

Castagnola C, Nozza A, Corso A, Bernasconi C. Castagnola C, et al. Among authors: corso a. Haematologica. 1997 Sep-Oct;82(5):577-80. Haematologica. 1997. PMID: 9407724 Clinical Trial.

10

Management of acute promyelocytic leukemia relapse in the ATRA era.

Castagnola C, Lunghi M, Corso A, Tajana M, Zappasodi P, Dabusti M, Lazzarino M, Bernasconi C. Castagnola C, et al. Among authors: corso a. Haematologica. 1998 Aug;83(8):714-7. Haematologica. 1998. PMID: 9793255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

469 results

Search Page

Filters